1. Home
  2. AMPL vs ANIP Comparison

AMPL vs ANIP Comparison

Compare AMPL & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$13.37

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$72.11

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPL
ANIP
Founded
2012
2001
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
AMPL
ANIP
Price
$13.37
$72.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
5
Target Price
$13.42
$110.00
AVG Volume (30 Days)
1.6M
308.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
11.84
419.23
EPS
N/A
2.32
Revenue
$343,214,000.00
$206,547,000.00
Revenue This Year
$17.43
$21.01
Revenue Next Year
$14.16
$17.59
P/E Ratio
N/A
$30.25
Revenue Growth
14.68
2.47
52 Week Low
$5.51
$69.58
52 Week High
$14.76
$99.39

Technical Indicators

Market Signals
Indicator
AMPL
ANIP
Relative Strength Index (RSI) 61.70 36.54
Support Level $6.05 $70.15
Resistance Level $14.76 $83.20
Average True Range (ATR) 0.60 1.76
MACD -0.22 -0.13
Stochastic Oscillator 60.50 12.62

Price Performance

Historical Comparison
AMPL
ANIP

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: